Last update 21 Nov 2024
Human papillomavirus 11-valent recombinant vaccine (National Vaccine and Serum Institute)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Prophylactic vaccine |
Synonyms- |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
5
Clinical Trials associated with Human papillomavirus 11-valent recombinant vaccine (National Vaccine and Serum Institute)多中心、随机、双盲、安慰剂对照评价11价重组人乳头瘤病毒疫苗（汉逊酵母）接种于18-45岁中国女性的保护效力、安全性和免疫原性的III期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the protective efficacy, safety and immunogenicity of 11-valent recombinant human papillomavirus vaccine (Hansen yeast) in Chinese women aged 18-45 years
A Multicenter Randomized, Blinded, Placebo-controlled Phase III Clinical Trial Evaluating the Protective Efficacy, Safety and Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years
随机盲法阳性对照设计评价11价重组人乳头瘤病毒疫苗接种于18-26岁中国女性的免疫原性和安全性II期临床试验
[Translation] A phase II randomized, blinded, positive-controlled clinical trial to evaluate the immunogenicity and safety of 11-valent recombinant human papillomavirus vaccine in Chinese women aged 18-26 years
100 Clinical Results associated with Human papillomavirus 11-valent recombinant vaccine (National Vaccine and Serum Institute)
Login to view more data
100 Translational Medicine associated with Human papillomavirus 11-valent recombinant vaccine (National Vaccine and Serum Institute)
Login to view more data
100 Patents (Medical) associated with Human papillomavirus 11-valent recombinant vaccine (National Vaccine and Serum Institute)
Login to view more data
100 Deals associated with Human papillomavirus 11-valent recombinant vaccine (National Vaccine and Serum Institute)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Human Papillomavirus Infection | Phase 3 | CN | 04 Jun 2022 | |
| Human Papillomavirus Infection | Phase 3 | CN | 04 Jun 2022 | |
| Human Papillomavirus Infection | Phase 3 | CN | 04 Jun 2022 | |
| Condylomata Acuminata | Preclinical | CN | 20 Jun 2020 | |
| Persistent Infection | Preclinical | CN | 20 Jun 2020 | |
| Persistent Infection | Preclinical | CN | 20 Jun 2020 | |
| Persistent Infection | Preclinical | CN | 20 Jun 2020 | |
| Vagina Carcinoma | Preclinical | CN | 20 Jun 2020 | |
| Vagina Carcinoma | Preclinical | CN | 20 Jun 2020 | |
| Vagina Carcinoma | Preclinical | CN | 20 Jun 2020 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free